Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|April 8, 2025
ASCPT 125th Anniversary: A Society Leadership PerspectiveMatthew L Rizk, Abigail Gorman, Sandra A G VisserClinical Pharmacology and Therapeutics|April 14, 2026
The Future of Clinical Translational PharmacologyMatthew L Rizk, Anuradha Ramamoorthy, Stephani L Stancil, et al.CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
Perspective on the State of Pharmacometrics and Systems Pharmacology IntegrationMirjam N Trame, Matthew Riggs, Konstantinos Biliouris, et al.Pharmaceutical Research|December 3, 2015
Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining FluidPyry A J Välitalo, Koen Griffioen, Matthew L Rizk, et al.British Journal of Clinical Pharmacology|February 8, 2016
Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluidJ G Coen van Hasselt, Matthew L Rizk, Mallika Lala, et al.Clinical Pharmacology and Therapeutics|December 23, 2025
The Role for Clinical Translational Pharmacology in Advancing PharmacoequitySonya Tang Girdwood, Sandra A G VisserPlos One|September 5, 2009
Ensemble modeling for aromatic production in Escherichia coliMatthew L Rizk, James C LiaoEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 17, 2017
Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD conceptsSandra A G Visser, Tjerk J H BuetersFuture Medicinal Chemistry|November 25, 2015
Optimization of human dose prediction by using quantitative and translational pharmacology in drug discoveryTjerk Bueters, Christopher Gibson, Sandra A G VisserDrug Discovery Today|May 14, 2013
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal livesTjerk Bueters, Bart A Ploeger, Sandra A G VisserPageof 10